Barcelona, Spain

Rut Olivar Miro



Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Rut Olivar Miro

Introduction

Rut Olivar Miro is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of immunology through her innovative research and patented inventions. Her work focuses on developing methods and compositions for the treatment of various immunological diseases.

Latest Patents

Rut Olivar Miro holds a patent for "Compositions and methods for immunomodulation." This invention relates to methods and reagents aimed at treating immunological diseases. Specifically, it involves isoforms of the C4b-binding protein (C4BP) that lack beta chains, as well as fragments and peptides derived from these isoforms. The patent outlines the therapeutic uses of these polypeptides for conditions such as immunoinflammatory diseases, sepsis, autoimmune diseases, transplant rejection, graft-versus-host disease, and hypersensitivity diseases. Additionally, the invention discusses the use of factor H for treating immunological diseases and the creation of tolerogenic dendritic cells using the C4BP isoform lacking beta chains.

Career Highlights

Rut Olivar Miro is affiliated with the Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), where she conducts her research. Her work has garnered attention for its potential impact on treating complex immunological conditions.

Collaborations

Rut collaborates with esteemed colleagues in her field, including Josep Maria Aran Perramon. Their joint efforts contribute to advancing research in immunology and developing innovative therapeutic solutions.

Conclusion

Rut Olivar Miro's contributions to immunology through her patented inventions highlight her role as a leading inventor in the field. Her work not only addresses critical health challenges but also paves the way for future advancements in immunological treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…